Nemonapride

Nemonapride

Nemonapride
Systematic (IUPAC) name
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
Clinical data
AHFS/Drugs.com
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Registry Number
ATC code None
PubChem CID:
IUPHAR/BPS
UNII  YesY
KEGG  YesY
Chemical data
Formula C21H26ClN3O2
Molecular mass 387.90 g/mol
 YesY   

Nemonapride (Emilace) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor